Three leading experts in iPS research discuss the current status of iPS cell technology with an emphasis on iPS methodology and use in research for human disease, drug screening and cell-based therapy.
Published: Thursday, 12 November, 2009
Since Yamanka et al first described generation of iPS cells in 2006, many variations to the reprogramming method have evolved to improve efficiency and safety for clinical applications. The webinar will cover important milestones since the original publication.
Speaker: Stephen Chang PhD, Chief Scientific Officer, Stemgent Inc
Published: Thursday, 07 January, 2010
The Stemgent® Lentivirus Reprogramming product line offers a broad selection of Dox-inducible and non-inducible reprogramming factors for mouse and human cells. The webinar covers validation and selection of reprogrammed cells as well as iPS colony morphology changes during reprogramming and how to identify which colonies to pick for expansion.
Speaker: Brad Hamilton, Sr. Scientist, Stemgent Inc
Published: Thursday, 07 January, 2010
Kyle Brueggeman, Product Manager, explains the expansion of the Your Favorite Gene Web site. We've added a biologically relevant literature search, new gene regulation and variation viewers, expression study results, clinical trials, detailed disease relationships, and biochemical compound interactions related to your gene of interest. Spend less time searching multiple sites and find it all in YFG. See what's new!
Published: Thursday, 29 April, 2010
A brief overview of epigenetic modifications and associated enzymes from Proteolysis.org
Published: Tuesday, 14 October, 2008